SCHEMBL1500263

SCHEMBL1500263

CC(=O)c1cn2cc(Br)ccc2n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 1/20 0.51
APP P05067 5/20 0.48
MAP3K5 Q99683 1/20 0.47
CLK1 P49759 1/20 0.44
DYRK1A Q13627 1/20 0.44
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
RXFP1 Q9HBX9 3/20 0.42
METTL3 Q86U44 1/20 0.42
PAX8 Q06710 1/20 0.41
HRH4 Q9H3N8 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
KMT2A Q03164 1/20 0.40
RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1500394 0.84 PTGS1 (0.57) PIK3CGAPPMAP3K5CLK1DYRK1A
SCHEMBL29540016 0.83 PIK3CG (0.56) PIK3CGAPPMAP3K5CLK1DYRK1A
SCHEMBL16376280 0.82 RAB9A (0.50) APPMAP3K5NPC1RAB9AALDH1A1
SCHEMBL1500335 0.82 PIK3CG (0.47) PIK3CGAPPMAP3K5CLK1DYRK1A
SCHEMBL1553322 0.82 PIK3CG (0.47) PIK3CGAPPMAP3K5CLK1DYRK1A
SCHEMBL1500262 0.82 PIK3CG (0.51) PIK3CGAPPMAP3K5CLK1DYRK1A
SCHEMBL15223780 0.81 HRH4 (0.41) MAP3K5NPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL1500236 0.80 KDM4E (0.64) NPC1RAB9AALDH1A1SMN1; SMN2RXFP1
SCHEMBL20646875 0.79 HRH4 (0.61) APPMAP3K5CLK1DYRK1ANPC1
SCHEMBL18883283 0.79 HRH4 (0.40) PIK3CGAPPNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731207-A2 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS Merck Sharp & Dohme LLC (US) 2026-04-29 EP disclosed
WO-2025006293-A2 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2025-01-02 WO disclosed
US-20110160208-A1 DIARYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2011-06-30 US disclosed
US-7902369-B2 Diaryl-substituted five-membered heterocycle derivative BANYU PHARMACEUTICAL CO., LTD. (JP) 2011-03-08 US disclosed
US-20070173507-A1 Dairyl-substituted five-membered heterocycle derivative MSD K.K. (JP) 2007-07-26 US disclosed
EP-1726585-A1 DIARYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-11-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160208-A1 DIARYL-SUBSTITUTED FIVE-MEMBERED HETEROCYCLE DERIVATIVE OPRK1, GRM1, GRIK1 PIK3CG 3385/4885APP 1929/4885MAP3K5 1148/4885
US-20070173507-A1 Dairyl-substituted five-membered heterocycle derivative OPRK1, OPRL1, GRM1 PIK3CG 2785/4885APP 2512/4885MAP3K5 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.